EP1578984A1 - Procede de preparation de bande de biodetection de lactate - Google Patents

Procede de preparation de bande de biodetection de lactate

Info

Publication number
EP1578984A1
EP1578984A1 EP02790636A EP02790636A EP1578984A1 EP 1578984 A1 EP1578984 A1 EP 1578984A1 EP 02790636 A EP02790636 A EP 02790636A EP 02790636 A EP02790636 A EP 02790636A EP 1578984 A1 EP1578984 A1 EP 1578984A1
Authority
EP
European Patent Office
Prior art keywords
silver
layer
electrode
lactate
graphite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02790636A
Other languages
German (de)
English (en)
Inventor
Manoj Kumar Pandey
Asha Chaubey
Krishan Kant Pande
Rajendra Kumar Sharma
Krishan Kumar Saini
Bansi Dhar Malhotra
Rajesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of EP1578984A1 publication Critical patent/EP1578984A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/005—Enzyme electrodes involving specific analytes or enzymes

Definitions

  • the invention relates to a lactate biosensing strip for the measurement of lactate solution.
  • the present invention also relates to a method for the manufacture of a novel lactate biosensing strip and to the use thereof for lactate sensing. Background of the invention
  • Clinical laboratories offer a wide range of automated systems for high- volume testing and analytical support in a well controlled, high quality environment. However, clinical laboratories can not provide the immediate results needed to properly treat trauma and multi organ dysfunction/failure patients.
  • technologies are emerging for testing using reliable, automated analyzers at the patient's bedside including electrochemical biosensors, optical fluorescence sensors, paramagnetic particles for coagulation test systems, and micromachined devices for both chemical and immunochemical testing. These technologies have allowed multi-analyte chemistry panels to be performed rapidly and addressed previous obstacles such as calibration of test devices.
  • in vitro tests can be classified as: 1) in vitro, which is performed at the bedside; 2) ex vivo or para vivo, which is performed at wrist-side; and 3) in vivo, which is performed inside the patient.
  • Such tests offer indirect cost efficiencies and savings such as reduced labor costs, decreased blood identification and transport errors, and reduced patient complications.
  • In vitro or bedside devices are used typically in several departments of the hospital including intensive care units; operating rooms; emergency departments (ER); interventional departments; general patient care departments; and outpatient surgery and ambulatory care units.
  • In vitro diagnostic tests offer a wide range of diagnostic tests, similar to the clinical laboratory. In vitro diagnostic test systems typically are not connected on-line to the patient and require an operator for blood sampling.
  • diagnostic test in the diagnostic market include arterial blood gases, blood chemistries, blood glucose, coagulation, drugs-of-abuse testing, hemoglobin, hematocrit, infectious diseases, and therapeutic drug monitoring.
  • Other categories include cancer markers, cardiac markers, cholesterol detection, immunodiagnostics, infectious disease detection, lactate, and thrombolytic monitoring.
  • Ex vivo diagnostics use external sensors for on-line real-time testing with little to no blood loss. Typically, sampled blood flows through a closed system to minimize blood contact. Ex vivo systems minimize problems associated with in vivo sensors, including clotting, inaccuracy, calibration drift, and an inability to recalibrate once in the patient.
  • U.S. Pat. No. 5,505,828 discloses an exemplary ex vivo system.
  • Ex vivo and in vivo diagnostics can reduce quality control and information integration errors that occur with clinical or in vitro tests.
  • Quality control errors are commonly due to operator errors, not instrument errors or device failures.
  • Exemplary errors include inappropriate specimen volume, inaccurate calibration, use of deteriorated test strips, inadequate validation, insufficient instrument maintenance, bad timing of the test procedure, and use of the wrong materials.
  • Clinical information system integration allows test data collected at the bedside to be put directly into the patient record. This improves the efficiency of the patient management process, allowing the integration of the laboratory's information system and clinical information systems, providing a "seamless" flow of all types of patient information..
  • Lactate is the byproduct of carbohydrate metabolism and product of glycolysis
  • lactate is converted into lactate under an aerobic condition i.e. deficiency of oxygen in cells. Lactate estimations are therefore important in respiratory disorder, heart ailment, labor deseases etc. normal concentration of lactate in human blood is in the range of 1.2 to 2.7mM.
  • Procedure for lactate determination for example, has employed a variety of chemical and physical technique.
  • Traditional assay involves chemical treatment of lactate in human blood and thereby converting it into colour products which can be measured spectrophotometrically, the methods consists in reacting the blood under test with enzyme namely lactate dehydrogenise (LDH).
  • LDH lactate dehydrogenise
  • absorbance at 340nm is measured due to the NADH formation, it becomes a measurement of lactate originally present in blood.
  • US Patent 6,117,290 discloses an on-line lactate sensor arrangement.
  • the sensor arrangement includes a lactate sensor, a catheter for withdrawing a test sample, and a first fluid flow line provided fluid communication between the lactate sensor and the catheter.
  • the sensor arrangement also includes a source of sensor calibration and anticoagulant solution, and second fluid flow line providing fluid communication between the source of sensor calibration and anticoagulant solution and the lactate sensor.
  • Asha Chaubey et al disclose in Electrochimica Acta Nol 46, 723 - 729 (2000) the immobilization of lactate dehydrogenase on electrochemically prepared polypyrrole polyvinyl sulphonate composite films. The response time reported is about 40 seconds and a shelf life of about 2 weeks under refrigerated conditions.
  • Asha Chaubey et al Analyticla Chimica Acta Nol 49, 98 - 103, 2000
  • the immobilization of lactate dehydrogenase on conducting polyaniline films is disclosed. The linearity of response is shown from O.lmM to lmM lactate concentration with a shelf life of about 3 weeks under refrigerated conditions. It is preferable to obtain sensors with longer shelf life and shorter response time. Accordingly, it is important to provide a lactate biosensing strip that can overcome the disadvantages of the prior art without losing out on efficiency and accuracy of measurement. Objects of the invention
  • the main object of this invention is to provide a novel lactate biosensing strip for the measurement of lactate in aqueous medium. It is another object of the invention to provide a lactate biosensing strip which performs rapidly and accurately the estimation of lactate in an aqueous medium.
  • a further object of this invention is an assay, which can be performed without the need for elaborate preliminary treatment of blood sample.
  • Another object of this invention is to proposed a lactate biosensing strip, which has a high activity of 75%.
  • Still another object of this invention is to proposed a lactate-sensing strip, which is capable for providing a reading at site.
  • Lactate biosensing strip have many advantages over traditional methods, such as fast response, small size convenience, specificity of response, lack of need of any sample preparation, low cost and high sensitivity of measurement.
  • the main advantage of this sensor over the traditional method is sample operation it can be done by ordinary person.
  • the present invention provides a lactate biosensing strip for use in the assay of lactate in a sample, said sensor comprising a dry strip sensor of an electrically conducting material having at least: i. an external surface. ii. a screen printed reference electrode and ⁇ i. a screen-printed working electrode.
  • the present invention provides a lactate sensor comprising an electrically insulated base support (1), a pair of isolated first and second silver layers deposited thereon (2), a pair of graphite layers, each one of said pair of graphite layers being deposited on one respective silver layer and electrically connected to said respective silver layer (2), the first silver layer being covered fully by the respective graphite layer, the second silver layer being covered partly in the middle thereof with the respective graphite layer leaving the connecting and working zone area of the said layer uncovered , a Ag/AgCl electrode (4) provided on top of the working zone area of said second silver electrode layer, lactate oxidase deposited with a mediator on the working zone area of graphite layer covering the first silver layer, the said silver/silver chloride reference electrode (4) and enzyme with mediator working electrode being supported on said support (1), the entire working areas of referene and working electrode being covered with a hydrophilic membrane.
  • the electrically insulated base support used is made of polyvinyl chloride.
  • the distance between the silver layers is in the range of 0.5 to 1mm
  • each silver layer is in the range of 15 to 25 microns.
  • the electron mediator layer comprises a layer of potassium ferricyanide or ferrocene.
  • the hydrophilic membrane is made of nylon or polyester.
  • the working zone are of electrode is a target area used for dispensing the analyte sample
  • the connecting terminal zone area of electrode is an area used for the connectivity of electrode to an electrometer
  • the lactate biosensing strip of the invention shows an activity of 75% and a response time for lactate detection is in the range of 30 to 40 seconds.
  • the shelf life of the strip of the invention is about 4 months under refrigerated conditions. Under ambient conditions (25 to 30°C) the shelf life of the biosensing strip is seen to be about 2 months.
  • the strip of the invention is disposable.
  • the invention also relates to a method for the manufacture of a lactate biosensing strip said strip comprising an electrically insulated base support (1), a pair of isolated first and second silver layers deposited thereon (2), a pair of graphite layers, each one of said pair of graphite layers being deposited on one respective silver layer and electrically connected to said respective silver layer (2), the first silver layer being covered fully by the respective graphite layer, the second silver layer being covered partly in the middle thereof with the respective graphite layer leaving the connecting and working zone area of the said layer uncovered, a Ag/AgCl electrode (4) provided on top of the working area of said second silver electrode layer, lactate oxidase deposited with a mediator on the working area of graphite layer covering the first silver layer (5), the said silver/silver chloride electrode (4) and enzyme with mediator working electrode being supported on said support (1), said process comprising
  • the electrically insulated base support comprises of polyvinyl chloride.
  • said silver layer used is applied by the step of screen-printing.
  • said graphite layer used is applied by the step of screen-printing.
  • the sample being tested is an aqueous lactate solution or blood sample in an amount of 25 to 30 ⁇ L.
  • the electron mediator used is selected from potassium ferricyanide and ferrocene.
  • connecting terminal zone area of electrode is an area used for the connectivity of electrode to an electrometer
  • the hydrophilic membrane is made of nylon or polyester.
  • Figure 1 is a schematic representation of the biosensing strip of the invention.
  • Figure 2 is the response curve of the lactate biosensing strip of the invention for standard lactate test samples.
  • Figure 3 shows the calibration curve for the sensor against standard lactate test samples prepared in a laboratory.
  • Figure 4 shows the shelf life stability characteristics of the lactate strip of the invention.
  • the invention comprises an electrically insulated base support
  • the electrode assembly comprises two electrode systems, a working electrode system (2), (3) and (5) consisting of a silver layer with a graphite layer deposited thereon and an enzyme and mediator layer adsorbed in the inorganic matrix.
  • the other electrode assembly comprises a reference electrode comprising a silver layer partly deposited with a graphite layer and a silver/silver chloride layer thereon.
  • Figure 1 shows the PNC sheet (i) which comprises the supporting substrate for the electrode.
  • Conducting silver tracking (ii) is the screen-printed conducting graphite layer onto the surface of conducting silver tracking (iii) for the connection of the sensor to read out apparatus.
  • the target area consists of the working electrode (iv) and the reference electrode (v) applies to the end of tracking by screen-printing.
  • An insulated layer is applied over the printed electrode to give them protection; the mass can be coated with one or more legends.
  • the conducting graphite track (ii) does not extend to the complete length of the silver track and the reference electrode.
  • the strip was used to detect currents when the lactate solutions were used in concentrations of 1 to 8mM. The current measured for each of the concentrations was measured and plotted in Figure 2.
  • curve (1) is the response curve for lmM lactate solution
  • curve (2) is for 2mM solution
  • curve (3) is for 4mM solution
  • curve (4) is for 6-----M solution
  • curve (5) is for 8mM solution.
  • the invention also provides a process for producing a lactate sensor strip which comprise in forming a first and second electrode on a substrate by applying a layer of silver for each of said electrodes in said electrode, applying a layer graphite on the handling zone of said second electrode to silver chloride, applying a mediator and enzyme on the graphite layer of the working zone of the first electrode.
  • An outer hydrophilic membrane is applied zone of said first electrode.
  • the silver layers and the graphite layers are preferably applied by the step of screen-printing.
  • the main feature of this invention is that the sensor is a dry strip sensor. It is found that a similar mix of reagents employed in a wet sensor system did not give good result across a desired range of detectable lactate concentration.
  • This invention comprises a substrate for supporting an electrode assembly said electrode assembly comprising two electrode systems, one working electrode and another one as a reference electrode supported on said substrate and disposed in a spaced relationship to each other.
  • the lactate sensing strip comprising of a substrate for supporting a first or working electrode and second or reference electrode, said electrode disposed- in a spaced relationship to each other.
  • the first electrode is a working electrode and has a terminal extending into a working zone through a handling zone.
  • the second electrode is a reference electrode and has a te ⁇ ninal extending into a working zone through a handling zone.
  • the respective terminals are of a material different to the base conducting layer of said first and second electrodes.
  • Commercially obtained lactate oxidase is mixed in a phosphate buffer, then proper amount of this solution is injected onto a preprinted working electrode. This solution is allowed to dry in allow temperature, followed by i. printing of conducting tracking ii. printing of reference electrode iii. printing of working electrode iv. fixing of membrane onto electrode.
  • the working and reference electrode each comprise a base conducting layer of silver material along the handling and working zone.
  • a graphite layer is deposited on the silver layer of the working electrode and extends to the terminal; the graphite layer is applied on the handling zone of the reference electrode and extends to the terminal.
  • Ag/AgCl is deposited on the target area of the reference electrode.
  • Working electrode comprising conducting surface carrying mediator compound and lactate oxidase enzyme.
  • mediator compound transfer electrodes from the enzyme to the electrode, when such catalytic activity takes place.
  • a hydrophilic membrane must be provided on the working zone of said electrode. It appears that the surfactant serves to break up the lipoprotein complex of blood and lactate is then oxidized to the pyruvate by the lactate oxidase.
  • the mediator compound is electrochemically reduced at the electrode producing a current measurable at the electrode, which current is relative to the activity of the lactate oxidize and hence the amount of lactate present in the sample this current is generated through a serious of coupled reactions
  • the redox mediator is oxidized at the base electrode and the current proportional to the lactate concentration. Current can be measured by any conventional electronic system.
  • the following examples are given by the way of illustration and therefore should not be construed as limiting the scope of the invention.
  • Example 1 Preparation of graphite paste with mediator lOOmg of graphite powder and polyvinyl pyrrolidon (binder) was mixed with 0.01M Potassium ferricyanide (mediator) in ethylene glycol monobutyl ether to prepare screen printable working electrode graphite paste.
  • Example 2 Preparation of Dry strip
  • lactate oxidase solution (2 ⁇ L) containing 2U of lactate oxidase was physically adsorbed on the mediator mixed graphite electrode strip and was kept over night to dry at 25°C.
  • the dry strip electrode was covered with a hydrophilic nylon membrane. Before the membrane was applied, it was placed in 10% surfactant (Tween 80) solution in distilled water for some time the dried membrane was then fixed over the strip.
  • Tween 80 10% surfactant
  • lactate oxidase converts 1-lactate to pyruvate and H 2 O 2 .
  • H 2 O 2 is subsequently converted into a colored dye by peroxidase in the presence of 4-amino antipyrine (4AAP) and dimethylaniline(DMA).
  • the dye absorbs at 565 nm at the light path of 1cm.
  • the activity of the immobilized enzyme was calculated according to the following formula:
  • U cm 2 AN/ ⁇ t s
  • A is the change in absorbance before and after incubation
  • N is the total volume (3ml)
  • ⁇ is the milimolar extinction coefficient of Quinonediimine dye at 565 nm (35.33)
  • t is the reaction time (10 min)
  • s is the surface area of the enzyme electrode
  • lactate biosensing strip comprising enzyme(LOD) immobilized on graphite as working electrode and Ag/AgCl reference electrode is connected to the input of the electrometer was polarized at a bias voltage of 0.4N for the measurement of amperometric calibration response to lactate (1-8 mM)( Figure 2).
  • a maximum current of 60 ⁇ A was obtained for 8 mM lactate solution above which no significant change in current could be observed.
  • the response time for lactate solution (1-8 mM) was found to be 40 seconds for each concentration of lactate ( Figure 3). Results were found to be reproducible to within 5%. Following principle was involved in the amperometric measutrements. Lactate + LOD (ox) * Pyruvate + LOD (red) LOD (red) + Fe 3+ ⁇ LOD (ox) + Fe 2+
  • the lactate biosensing strip provides a quick estimation of lactate in a sample 2.
  • the shelf life of the sample is 4 months under refrigerated conditions.
  • the strip has a linear response in a lactate concentration of 1 to 8 mM.
  • the strip is disposable without causing any environmental hazard.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne un procédé de fabrication d'une bande de biodétection de lactate destinée au dosage de lactate dans un échantillon, ce détecteur comprenant un détecteur en bande sèche d'un matériau électriquement conducteur possédant au moins: (i) une surface externe, (ii) une électrode de référence imprimée à l'écran et, (iii) une électrode de travail imprimée à l'écran
EP02790636A 2002-12-31 2002-12-31 Procede de preparation de bande de biodetection de lactate Withdrawn EP1578984A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/005677 WO2004058992A1 (fr) 2002-12-31 2002-12-31 Procede de preparation de bande de biodetection de lactate

Publications (1)

Publication Number Publication Date
EP1578984A1 true EP1578984A1 (fr) 2005-09-28

Family

ID=32676718

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02790636A Withdrawn EP1578984A1 (fr) 2002-12-31 2002-12-31 Procede de preparation de bande de biodetection de lactate

Country Status (6)

Country Link
EP (1) EP1578984A1 (fr)
JP (1) JP2006512571A (fr)
CN (1) CN100372940C (fr)
AU (1) AU2002368512A1 (fr)
CA (1) CA2512279C (fr)
WO (1) WO2004058992A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606998D0 (en) * 2006-04-06 2006-05-17 Oxford Biosensors Ltd Lipoprotein sensor
CN101344501B (zh) * 2008-08-22 2011-10-05 中南大学 一种丝网印刷电极、制备工艺及其应用
JP2010230369A (ja) * 2009-03-26 2010-10-14 Ryukoku Univ 電極構造及び当該電極構造の製造方法並びに電気化学センサ
CN101650331B (zh) * 2009-08-27 2012-09-05 无锡爱康生物科技有限公司 一种酶生物电化学传感芯片及其制备方法
KR101947639B1 (ko) * 2017-08-08 2019-02-14 한국화학연구원 그래핀 전극 기반 체외진단용 글루코스 센서
US20190320947A1 (en) * 2018-04-19 2019-10-24 Abbott Diabetes Care Inc. Lactate sensors and associated methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5682884A (en) * 1983-05-05 1997-11-04 Medisense, Inc. Strip electrode with screen printing
US5707502A (en) * 1996-07-12 1998-01-13 Chiron Diagnostics Corporation Sensors for measuring analyte concentrations and methods of making same
CO5040209A1 (es) * 1997-10-16 2001-05-29 Abbott Lab Electrodos biosensores mediadores de la regeneracion de cofactores

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004058992A1 *

Also Published As

Publication number Publication date
CN1742092A (zh) 2006-03-01
JP2006512571A (ja) 2006-04-13
CN100372940C (zh) 2008-03-05
CA2512279A1 (fr) 2004-07-15
CA2512279C (fr) 2010-06-29
WO2004058992A1 (fr) 2004-07-15
AU2002368512A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
US6033866A (en) Highly sensitive amperometric bi-mediator-based glucose biosensor
D'Orazio Biosensors in clinical chemistry
US5695947A (en) Amperometric cholesterol biosensor
US9039874B2 (en) Disposable urea sensor and system for determining creatinine and urea nitrogen-to-creatinine ratio in a single device
US5108564A (en) Method and apparatus for amperometric diagnostic analysis
Magner Trends in electrochemical biosensors
US20070205114A1 (en) Method of detecting biosensor filling
US5876952A (en) Non-invasive glucose biosensor: determination of glucose in urine
US20110053192A1 (en) Method Of Rapid Detection Of An Analyte In Bodily Fluids Using A Fluorescent Dry Test Strip Biosensor
Higson et al. Enzyme and other biosensors: Evolution of a technology
Endo et al. A needle-type optical enzyme sensor system for determining glucose levels in fish blood
CA2512279C (fr) Procede de preparation de bande de biodetection de lactate
US7364873B2 (en) Method for manufacture of lactate biosensing strip
US7319018B2 (en) Lactate biosensing strip with two electrodes
Li et al. An amperometric bienzyme biosensor for rapid measurement of alanine aminotransferase in whole blood
Davis Advances in biomedical sensor technology: a review of the 1985 patent literature
CA2512281C (fr) Bande de biodetection de lactate
US20150260677A1 (en) Method For Manufacturing A Lot Of Test Sensors
CN214622434U (zh) 一种电化学生物传感器
US5741709A (en) Multiple injection analysis
RU2049991C1 (ru) Способ определения метаболитов в биологических жидкостях, активный элемент для его осуществления
Chen et al. Disposable glucose test strip for whole blood with integrated sensing/diffusion-limiting layer
US10746687B2 (en) Method for measuring target component and apparatus for measuring target component
Arya An Overview of Amperometric Biosensors for Clinical and Medicinal Drug Monitoring
Urban et al. Biosensors with modified electrodes for in vivo and ex vivo applications

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050726

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20061214

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081029